Showing results (241-250 of 283) with videos related to

Sort By:
Pageof 29
European Radiology|May 8, 2012
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancerR S Gillies, M R Middleton, C Blesing, et al.
British Journal of Cancer|May 14, 2008
A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancerO A Khan, M Ranson, M Michael, et al.
The British Journal of Surgery|October 13, 2015
Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopyJ M Findlay, K M Bradley, E J Maile, et al.
Drugs|July 19, 2015
Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UKR Califano, N Tariq, S Compton, et al.
Oncogene|December 5, 1998
Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpressionS Vonlanthen, J Heighway, M P Tschan, et al.
International Journal of Oncology|January 6, 2011
Circulating melanoma cells and survival in metastatic melanomaC Rao, T Bui, M Connelly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2017
Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanomaR J Lee, G Gremel, A Marshall, et al.
The Medical Journal of Australia|February 7, 1981
Renal transplantation. 12-Year experienceP E Hurst, J G Brockis, R L Dawkins, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2015
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analysesP Mitchell, N Thatcher, M A Socinski, et al.
The British Journal of Surgery|January 18, 2017
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancerJ M Findlay, K M Bradley, L M Wang, et al.
Pageof 29